Technology
Health
Pharmaceutical

Oramed Pharmaceuticals

$3.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (6.50%) As of 2:20 PM EDT today
+$0.23 (6.50%) Today

Why Robinhood?

You can buy or sell ORMP and other stocks, options, ETFs, and crypto commission-free!

About ORMP

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Read More The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

Employees
13
Headquarters
Jerusalem, Jerusalem
Founded
2002
Market Cap
61.54M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
45.54K
High Today
$3.77
Low Today
$3.46
Open Price
$3.54
Volume
68.64K
52 Week High
$5.91
52 Week Low
$2.78

Collections

Technology
Health
Pharmaceutical
Research And Development
Asia (Non-China)
Asia

ORMP Earnings

-$0.30
-$0.26
-$0.22
-$0.18
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$0.23 per share
Actual
Expected Jul 25, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.